Related Experiment Video
Updated: Oct 9, 2025
06:32
Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.5K
Reduced Risk of Reoperations With Modern Deep Brain Stimulator Systems: Big Data Analysis From a United States Claims
Chengyuan Wu1, Sean J Nagel2, Rahul Agarwal3
1Department of Neurological Surgery, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia, PA, United States.
Frontiers in Neurology
|December 20, 2021
Summary
Modern deep brain stimulation (DBS) systems significantly reduce reoperation rates by 36% in patients with Parkinson's disease (PD) or essential tremor (ET), indicating improved safety and outcomes.
Area of Science:
- Neurosurgery
- Medical Device Technology
- Neurology
Background:
- Deep brain stimulation (DBS) systems have advanced, but their impact on complication rates remains understudied.
- Previous research has not comprehensively evaluated modern DBS systems against traditional ones regarding post-implantation complications.
Purpose of the Study:
- To compare the reoperation rates between modern directional (MD) and traditional omnidirectional (TO) DBS systems in patients with Parkinson's disease (PD) or essential tremor (ET).
- To assess the influence of modern DBS system implantation on complication rates in a large, real-world patient cohort.
Main Methods:
- Retrospective, contemporaneous cohort study utilizing US Centers for Medicare and Medicaid Services administrative claims data (2016-2018).
- Analysis of 3,869 patients undergoing de novo DBS implantation for PD or ET, comparing MD versus TO systems.
- Kaplan-Meier analysis and regression models were used to evaluate reoperation rates and influential covariates.
Main Results:
- Patients implanted with modern DBS systems showed a 36% lower likelihood of requiring reoperation compared to those with traditional systems.
- This risk reduction was primarily driven by fewer acute and intracranial lead reoperations.
- The benefit of modern systems was more pronounced in patients with Parkinson's disease and persisted after adjusting for practice and center experience.
Conclusions:
- Modern DBS systems are associated with significantly lower reoperation rates, suggesting improved device-related safety.
- The findings highlight the importance of considering modern system technology during device selection for DBS in PD and ET patients.
- Further prospective studies are warranted to elucidate the specific mechanisms behind these improved outcomes.
